Polymorphism of the apolipoprotein E and angiotensin-converting enzyme genes in Japanese subjects with silent myocardial ischemia.

The apolipoprotein epsilon4 allele and homozygous deletion allele (DD) of the angiotensin-converting enzyme gene are reported to be associated with an increase in the incidence of ischemic heart disease. In this study, we examined whether the apolipoprotein epsilon4 genotype and angiotensin-converting enzyme/DD allele are associated with silent myocardial ischemia. We screened 3920 subjects undergoing general checkups who no symptoms of ischemic heart disease. Seventy subjects (2 percent) showed ischemic ST-segment depression during the double two-step exercise test. One hundred and twenty control subjects without ischemic ST-segment depression were recruited from the same population and matched for sex, age, and blood pressure. We performed genotyping of the apolipoprotein E gene (epsilon2, epsilon3, and epsilon4) and angiotensin-converting enzyme gene (I and D) using polymerase chain reaction-restriction fragment length polymorphism and polymerase chain reaction, respectively. Allele frequently of epsilon4 of the apolipoprotein E gene was higher in the ischemic group (11 percent) than the nonischemic group (5 percent) (chi2 = 5.35, P < .05), but there was no significant association between the allele or the genotype frequency of the angiotensin-converting enzyme gene and the incidence of ischemic ST-segment depression. Furthermore, stepwise multiple regression analysis also revealed that total cholesterol level and epsilon4 genotype were predictors of ischemic change in the exercise tolerance test (chi2 = 12.8, P < .005, R(2) = .051). These results suggest that the apolipoprotein epsilon4 allele is an independent genetic risk factor for silent myocardial ischemia in Japanese subjects.

[1]  Meyers Br,et al.  Transesophageal echocardiography in the diagnosis of traumatic rupture of the aorta. , 1995 .

[2]  D. Wilcken,et al.  Polymorphisms of the apolipoprotein E gene and severity of coronary artery disease defined by angiography. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[3]  T. Yee,et al.  Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease , 1995, The Lancet.

[4]  J. Higaki,et al.  Enhanced predictability of myocardial infarction in Japanese by combined genotype analysis. , 1995, Hypertension.

[5]  J M Lalouel,et al.  Angiotensin-converting enzyme gene polymorphism is associated with myocardial infarction but not with development of coronary stenosis. , 1995, Circulation.

[6]  R Kreutz,et al.  A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. , 1995, The New England journal of medicine.

[7]  N. Iwai,et al.  DD Genotype of the Angiotensin‐Converting Enzyme Gene Is a Risk Factor for Left Ventricular Hypertrophy , 1994, Circulation.

[8]  K. Nakai,et al.  Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with serum ACE concentration and increased risk for CAD in the Japanese. , 1994, Circulation.

[9]  T. Ogihara,et al.  Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. , 1994, The New England journal of medicine.

[10]  C. Sing,et al.  Apolipoprotein E polymorphism and heterozygous familial hypercholesterolemia. Sex-specific effects. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[11]  P Ducimetière,et al.  Synergistic effects of angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction , 1994, The Lancet.

[12]  P. de Knijff,et al.  ApoE polymorphism and predisposition to coronary heart disease in youths of different European populations. The EARS Study. European Atherosclerosis Research Study. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[13]  D. Arveiler,et al.  Impact of apolipoprotein E polymorphism on lipoproteins and risk of myocardial infarction. The ECTIM Study. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[14]  L. Tiret,et al.  Plasma Level and Gene Polymorphism of Angiotensin‐Converting Enzyme in Relation to Myocardial Infarction , 1994, Circulation.

[15]  H. Schunkert,et al.  Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. , 1994, The New England journal of medicine.

[16]  H. Krutzsch,et al.  Apolipoprotein E: A potent inhibitor of endothelial and tumor cell proliferation , 1994, Journal of cellular biochemistry.

[17]  A. Goldberg,et al.  ApoE4 polymorphism increases the risk for exercise-induced silent myocardial ischemia in older men. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[18]  C. Bisgaier,et al.  Apolipoprotein E modulates low density lipoprotein retention by lipoprotein lipase anchored to the subendothelial matrix. , 1993, The Journal of biological chemistry.

[19]  D. Arveiler,et al.  Deletion polymorphism in angiotensin-converting enzyme gene associated with parental history of myocardial infarction , 1993, The Lancet.

[20]  L. Kuller,et al.  Relation of apolipoprotein E phenotype to myocardial infarction and mortality from coronary artery disease. , 1993, The American journal of cardiology.

[21]  Philippe Amouyel,et al.  Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction , 1992, Nature.

[22]  L. Tiret,et al.  Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. , 1992, American journal of human genetics.

[23]  J. Hixson Apolipoprotein E polymorphisms affect atherosclerosis in young males. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[24]  M. Emi,et al.  Genotyping and sequence analysis of apolipoprotein E isoforms. , 1988, Genomics.

[25]  L. T. Sheffield,et al.  Predictive value of the exercise tolerance test for mortality in North American men: the Lipid Research Clinics Mortality Follow-up Study. , 1986, Circulation.

[26]  K. Anderson,et al.  Epidemiology of diabetes mellitus in the elderly. The Framingham Study. , 1986, The American journal of medicine.

[27]  L. Curtiss,et al.  Apolipoprotein E is a biologically active constituent of the normal immunoregulatory lipoprotein, LDL-In. , 1986, Journal of immunology.

[28]  P. Cohn,et al.  Silent myocardial ischemia: dimensions of the problem in patients with and without angina. , 1986, The American journal of medicine.

[29]  A. Morabito,et al.  Prognostic value of exercise EKG testing in asymptomatic normotensive subjects. A prospective matched study. , 1983, The New England journal of medicine.

[30]  K.,et al.  Apoprotein E suppresses phytohemagglutinin-activated phospholipid turnover in peripheral blood mononuclear cells. , 1982, The Journal of biological chemistry.

[31]  B. K. Das,et al.  Master double two step exercise (DMT) with telemetry and submaximal treadmill exercise. A comparative study. , 1980, Indian heart journal.

[32]  A. Master Exercise testing for evaluation of cardiac performance. , 1972, The American journal of cardiology.

[33]  M. Nieminen,et al.  Lipoproteins and their genetic variation in subjects with and without angiographically verified coronary artery disease. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[34]  C. Sing,et al.  Apolipoprotein E polymorphism and atherosclerosis. , 1988, Arteriosclerosis.